Literature DB >> 15513440

Photodynamic therapy of age-related macular degeneration: History and principles.

H van den Bergh1.   

Abstract

We briefly review the history and principles of photodynamic therapy (PDT), especially as it is applied to choroidal neovascularization (CNV) in age-related macular degeneration (AMD). After a brief general history of PDT, we discuss the relationship between the physicochemical structure and photodynamic activity of the second-generation photosensitizers, such as those in current clinical use. We then discuss the basic photophysics of photosensitizer molecules, and describe the initial chemical reactions induced by activated sensitizers. We outline a novel method for screening photosensitizers to be used in treating CNV, as well as the complex biomolecular pathways modulated by PDT-induced oxidative stress and the vascular effects of PDT in solid tumors. The paper closes with a discussion of how all this information might be used to improve the selectivity and efficacy of clinically useful photosensitizers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 15513440     DOI: 10.1076/soph.16.4.181.10299

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  19 in total

1.  Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.

Authors:  Alejandro Arboleda; Darlene Miller; Florence Cabot; Mukesh Taneja; Mariela C Aguilar; Karam Alawa; Guillermo Amescua; Sonia H Yoo; Jean-Marie Parel
Journal:  Am J Ophthalmol       Date:  2014-04-29       Impact factor: 5.258

2.  Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Shunichiro Nakai; Wataru Matsumiya; Akiko Miki; Shigeru Honda; Makoto Nakamura
Journal:  Jpn J Ophthalmol       Date:  2019-08-02       Impact factor: 2.447

3.  Bystander effects induced by diffusing mediators after photodynamic stress.

Authors:  Asima Chakraborty; Kathryn D Held; Kevin M Prise; Howard L Liber; Robert W Redmond
Journal:  Radiat Res       Date:  2009-07       Impact factor: 2.841

4.  The association of age-related maculopathy susceptibility 2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Hiroaki Bessho; Shigeru Honda; Naoshi Kondo; Akira Negi
Journal:  Mol Vis       Date:  2011-04-20       Impact factor: 2.367

5.  Retinal nitric oxide and malonyldialdehyde levels following photodynamic therapy.

Authors:  Peykan Turkuoglu; Cem Ozturkmen; Nevin Ilhan; Julide Kurt; Orhan Aydemir; Ulku Celiker; Mohamed A Ibrahim; Aymen Rashid
Journal:  Indian J Ophthalmol       Date:  2011 Jan-Feb       Impact factor: 1.848

6.  The association of CD36 variants with polypoidal choroidal vasculopathy compared to typical neovascular age-related macular degeneration.

Authors:  Hiroaki Bessho; Shigeru Honda; Naoshi Kondo; Sentaro Kusuhara; Yasutomo Tsukahara; Akira Negi
Journal:  Mol Vis       Date:  2012-01-18       Impact factor: 2.367

7.  Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion.

Authors:  Patrycja Nowak-Sliwinska; Andrea Weiss; Judy R van Beijnum; Tse J Wong; Jean-Pierre Ballini; Blaise Lovisa; Hubert van den Bergh; Arjan W Griffioen
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

8.  Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy.

Authors:  Shigeru Honda; Hiroaki Bessho; Naoshi Kondo; Sentaro Kusuhara; Yasutomo Tsukahara; Akira Negi
Journal:  Mol Vis       Date:  2012-11-22       Impact factor: 2.367

9.  The effect of ranibizumab versus photodynamic therapy on DNA damage in patients with exudative macular degeneration.

Authors:  M Mozaffarieh; A Schötzau; T Josifova; Josef Flammer
Journal:  Mol Vis       Date:  2009-06-13       Impact factor: 2.367

10.  Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis.

Authors:  Witold W Kilarski; Angelika Muchowicz; Malgorzata Wachowska; Renata Mężyk-Kopeć; Jakub Golab; Melody A Swartz; Patrycja Nowak-Sliwinska
Journal:  Angiogenesis       Date:  2013-07-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.